USE OF CTLA4-Ig IN COMBINATION WITH CONVENTIONAL IMMUNOSUPPRESSIVE AGENTS TO PROLONG ALLOGRAFT SURVIVAL

Abstract

These data suggest that CTLA4-Ig may be effective clinically in combination with cyclosporine or sirolimus but offers no additional effectiveness in combination with antilymphocyte serum with or without donor-specific bone marrow.